Risk regulation in the single market: the governance of pharmaceuticals and foodstuffs in the European Union

This book demonstrates how the Thalidomide catastrophe of the 1960s and the BSE crisis of the 1990s led to regulatory regimes for pharmaceuticals and foodstuffs in Europe. However, the developmental paths of these regimes differ b and so does the efficiency and legitimacy of regulatory policy-making. ÍNDICE: Introduction: The Need for a Systematic Analysis of Supranational Risk Regulation - PART I: AN INSTITUTIONALIST APPROACH TO SUPRANATIONAL RISK REGULATION - Functional Pressure and Path-Dependencies: The Emergence and Development of Supranational Regulatory Regimes - Efficiency and Legitimacy: The Evaluation of Supranational Regulatory Regimes - PART II: THE AUTHORIZATION OF PHARMACEUTICALS IN THE EU - From National Crises to a Strong Supranational Regime: The Development of Pharmaceutical Authorization in Europe - A Strong Regulatory Network: The Evaluation of the European Regulatory Regime for Pharmaceuticals - PART III: THE REGULATION OF FOODSTUFFS IN THE EU - From an Early Single Market to a Crisis of Consumer Confidence: The Development of Foodstuff Regulation in Europe - A Weak Supranational Agency: The Evaluation of the EuropeanRegulatory Regime for Foodstuffs - PART IV: CONCLUSION - A Comparison of Pharmaceutical and Foodstuff Regulation in Europe

• ISBN: 978-0-230-53765-1
• Editorial: Palgrave Macmillan
• Encuadernacion: Cartoné
• Páginas: 240
• Fecha Publicación: 31/10/2008
• Nº Volúmenes: 1
• Idioma: Inglés